Cargando…
Serum amyloid A and Janus kinase 2 in a mouse model of diabetic kidney disease
BACKGROUND: Serum amyloid A (SAA), a potent inflammatory mediator, and Janus kinase 2 (JAK2), an intracellular signaling kinase, are increased by diabetes. The aims were to elucidate: 1) a JAK2-mediated pathway for increased SAA in the kidneys of diabetic mice; 2) a JAK2-SAA pathway for inflammation...
Autores principales: | Dieter, Brad P., Meek, Rick L., Anderberg, Robert J., Cooney, Sheryl K., Bergin, Jen L., Zhang, Hongyu, Nair, Viji, Kretzler, Matthias, Brosius, Frank C., Tuttle, Katherine R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375550/ https://www.ncbi.nlm.nih.gov/pubmed/30763329 http://dx.doi.org/10.1371/journal.pone.0211555 |
Ejemplares similares
-
Serum amyloid A and inflammation in diabetic kidney disease and podocytes
por: Anderberg, Robert J, et al.
Publicado: (2015) -
Serum amyloid A and inflammation in diabetic kidney disease and podocytes
por: Anderberg, Robert J, et al.
Publicado: (2015) -
Novel Therapies for Diabetic Kidney Disease: Storied Past and Forward Paths
por: Dieter, Brad P., et al.
Publicado: (2015) -
Enhanced Expression of Janus Kinase–Signal Transducer and Activator of Transcription Pathway Members in Human Diabetic Nephropathy
por: Berthier, Celine C., et al.
Publicado: (2009) -
Targeted Lipidomic and Transcriptomic Analysis Identifies Dysregulated Renal Ceramide Metabolism in a Mouse Model of Diabetic Kidney Disease
por: Sas, Kelli M, et al.
Publicado: (2015)